Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Depreciation and Depletion: 2019-2021

Historic Depreciation and Depletion for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2021 value amounting to $123,000.

  • Black Diamond Therapeutics' Depreciation and Depletion rose 720.00% to $123,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $205,000, marking a year-over-year increase of 294.23%. This contributed to the annual value of $343,000 for FY2024, which is 21.51% down from last year.
  • Black Diamond Therapeutics' Depreciation and Depletion amounted to $123,000 in Q4 2021, which was up 186.05% from $43,000 recorded in Q3 2021.
  • In the past 5 years, Black Diamond Therapeutics' Depreciation and Depletion registered a high of $123,000 during Q4 2021, and its lowest value of $9,000 during Q4 2019.
  • Over the past 3 years, Black Diamond Therapeutics' median Depreciation and Depletion value was $13,500 (recorded in 2019), while the average stood at $25,333.
  • Per our database at Business Quant, Black Diamond Therapeutics' Depreciation and Depletion declined by 16.67% in 2020 and then surged by 720.00% in 2021.
  • Over the past 3 years, Black Diamond Therapeutics' Depreciation and Depletion (Quarterly) stood at $9,000 in 2019, then soared by 66.67% to $15,000 in 2020, then soared by 720.00% to $123,000 in 2021.
  • Its last three reported values are $123,000 in Q4 2021, $43,000 for Q3 2021, and $20,000 during Q2 2021.